Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Vaughn Bryan T
EVP and President, Diagnostics·Direct
Exercise · Acquire
Common Stock
Shares+327
Price-
Total Value$0
Shares Owned After7.07K
Transaction DateJul 1, 2026
10b5-1
Footnotes ▸
Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
Vaughn Bryan T
EVP and President, Diagnostics·Direct
Tax W/H · Dispose
Common Stock
Shares-93
Price$283.88
Total Value$26.4K
Shares Owned After6.98K
Transaction DateJul 1, 2026
10b5-1
Footnotes ▸
Stock withholding to satisfy tax withholding obligations.
Vaughn Bryan T
EVP and President, Diagnostics·Direct
Exercise · Dispose
Restricted Stock UnitDerivative
Shares-327
Price$0.00
Total Value$0
Shares Owned After3.70K
Transaction DateJul 1, 2026
10b5-1
Footnotes ▸
Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. | The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on July 1, 2026. | The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on July 1, 2026. | This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
Post-Transaction Holdings
Vaughn Bryan T
Security
Shares
Change
Common Stock
6.75K
-
Restricted Stock Unit
3.70K
-327 (-8.11%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-07-01
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: LABCORP HOLDINGS INC. (LH)
CIK: 0000920148
--- Reporting Owner ---
Name: Vaughn Bryan T
CIK: 0002103999
Role: Officer (EVP and President, Diagnostics)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-07-01 | Code: M (Exercise of derivative)
Shares: +327
Shares Owned After: 7,072.5702 | Ownership: D (Direct)
Footnotes:
[F1] Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
[Transaction #2]
Security: Common Stock
Date: 2026-07-01 | Code: F (Payment of exercise/tax)
Shares: -93 | Price: $283.88
Total Value: $26,400.84
Shares Owned After: 6,979.5702 | Ownership: D (Direct)
Footnotes:
[F2] Stock withholding to satisfy tax withholding obligations.
[Transaction #3]
Security: Common Stock
Date: 2026-07-02 | Code: S (Open market sale)
Shares: -234 | Price: $286.19
Total Value: $66,968.46
Shares Owned After: 6,745.5702 | Ownership: D (Direct)
Footnotes:
[F3] Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
--- Derivative Transactions ---
[Transaction #1]
Security: Restricted Stock Unit
Date: 2026-07-01 | Code: M (Exercise of derivative)
Shares: -327 | Price: $0.00
Shares Owned After: 3,704 | Ownership: D (Direct)
Footnotes:
[F1] Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
[F4] The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on July 1, 2026.
[F4] The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on July 1, 2026.
[F5] This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
--- Footnotes (Complete Index) ---
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
F2: Stock withholding to satisfy tax withholding obligations.
F3: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F4: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on July 1, 2026.
F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
--- Signature ---
/s/ /s/ Kathryn W. Kyle, Attorney-in-Fact for Bryan T. Vaughn (2026-07-06)